Invitation to Submit Proposals under Agreements 2023/438 - Human Plasma Derivatives, 2023/671 - Various Medicines, and 2025/1589 - Various Medicines for the Acquisition of Plasma-Derived Medicinal Products

This tender is an invitation for proposals specifically for the acquisition of plasma-derived medicinal products. The procurement is conducted under the framework of three distinct agreements: 2023/438, which focuses on human plasma derivatives; 2023/671, covering various general medicines; and 2025/1589, also for various medicines. The primary objective is to secure a supply of essential plasma-derived therapies, which are critical for treating a range of medical conditions, including immune deficiencies, bleeding disorders, and certain critical care situations. By leveraging existing framework agreements, the procuring entity aims to expedite the acquisition process and ensure the availability of these specialized and often life-saving medications. Bidders are required to submit proposals that align with the specifications and requirements outlined for each of the referenced agreements, particularly concerning the plasma-derived products. This initiative underscores the importance of a robust supply chain for these vital therapeutic agents, ensuring that healthcare providers have access to the necessary treatments for patients requiring them. The tender seeks qualified suppliers capable of meeting stringent quality and regulatory standards for pharmaceutical products.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 67.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.